Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapyMichèle Cavo, Michele Baccarani, Delia Cangini et al.|Blood|2002Cited by 152
Thalidomide–dexamethasone as up‐front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low‐dose warfarinMichela Cini, Michèle Cavo, Elena Zamagni et al.|European Journal Of Haematology|2010Cited by 34